UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐Year Clinical Trial

Journal of bone and mineral research, 2019-12, Vol.34 (12), p.2220-2228

2019

Volltextzugriff (PDF)

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

The journal of clinical endocrinology and metabolism, 2022-04, Vol.107 (5), p.1441-1460

2022

Volltextzugriff (PDF)

Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review

Journal of clinical medicine, 2021-01, Vol.10 (1), p.152

2021

Volltextzugriff (PDF)

Clinical complications following thyroid fine-needle biopsy: a systematic review

Clinical endocrinology (Oxford), 2009-08, Vol.71 (2), p.157-165

2009

Volltextzugriff (PDF)

Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis

Thyroid (New York, N.Y.), 2010-10, Vol.20 (10), p.1163

2010

Volltextzugriff (PDF)

Efficacy of denosumab monotherapy among adults with Langerhans cell histiocytosis: A prospective clinical trial

American journal of hematology, 2023-07, Vol.98 (7), p.E168-E171

2023

Volltextzugriff (PDF)

Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis

Clinical endocrinology (Oxford), 2013-10, Vol.79 (4), p.499-503

2013

Volltextzugriff (PDF)

Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?

Metabolism, clinical and experimental, 2019-04, Vol.93, p.100-102

2019

Volltextzugriff (PDF)

Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature

Biomedicines, 2021-04, Vol.9 (5), p.475

2021

Volltextzugriff (PDF)

Adult Langerhans Cell Histiocytosis and the Skeleton

Journal of clinical medicine, 2022-02, Vol.11 (4), p.909

2022

Volltextzugriff (PDF)

Gender Predilection in Sporadic Parathyroid Adenomas

International journal of molecular sciences, 2020-04, Vol.21 (8), p.2964

2020

Volltextzugriff (PDF)

Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation

Bone Reports, 2020-06, Vol.12, p.100267, Article 100267

2020

Volltextzugriff (PDF)

The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?

Journal of clinical medicine, 2021-03, Vol.10 (5), p.996

2021

Volltextzugriff (PDF)

Physiological parameters regulating circulating levels of the IGFBP-4/Stanniocalcin-2/PAPP-A axis

Metabolism, clinical and experimental, 2017-10, Vol.75, p.16-24

2017

Volltextzugriff (PDF)

A Systematic Review of Cases Reporting Needle Tract Seeding Following Thyroid Fine Needle Biopsy

World journal of surgery, 2010-04, Vol.34 (4), p.844-851

2010

Volltextzugriff (PDF)

Novel therapies for osteoporosis

Metabolism, clinical and experimental, 2015-10, Vol.64 (10), p.1199-1214

2015

Volltextzugriff (PDF)

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab

Journal of clinical medicine, 2023-09, Vol.12 (18), p.5874

2023

Volltextzugriff (PDF)

Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease

Journal of bone and mineral metabolism, 2016-07, Vol.34 (4), p.447-456

2016

Volltextzugriff (PDF)

Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature

Journal of clinical medicine, 2022-11, Vol.11 (22), p.6863

2022

Volltextzugriff (PDF)

Clinical Features of 24 Patients With Rebound‐Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases

Journal of bone and mineral research, 2017-06, Vol.32 (6), p.1291-1296

2017

Volltextzugriff (PDF)

Off-label uses of denosumab in metabolic bone diseases

Bone (New York, N.Y.), 2019-12, Vol.129, p.115048-115048, Article 115048

2019

Volltextzugriff (PDF)

Bone disease in primary hyperparathyroidism

Metabolism, clinical and experimental, 2018-03, Vol.80, p.57-65

2018

Volltextzugriff (PDF)

Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study

Metabolism, clinical and experimental, 2019-12, Vol.101, p.154005-154005, Article 154005

2019

Volltextzugriff (PDF)

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

The journal of clinical endocrinology and metabolism, 2021-01, Vol.106 (1), p.264-281

2021

Volltextzugriff (PDF)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients

Bone Reports, 2021-12, Vol.15, p.101128-101128, Article 101128

2021

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(157)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(137)
Science & Technology
(137)
Humans
(100)
Endocrinology & Metabolism
(98)
Female
(72)
Osteoporosis
(58)
Denosumab
(39)
Middle Aged
(37)
Male
(33)
Aged
(32)
Medicine
(31)
Medicine & Public Health
(31)
Endocrinology
(29)
Adult
(25)
Bone Density Conservation Agents - Therapeutic Use
(25)
Bone Mineral Density
(25)
Osteoporosis, Postmenopausal - Drug Therapy
(23)
Fractures
(21)
Biological And Medical Sciences
(19)
Fracture
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐Year Clinical Trial

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review

Clinical complications following thyroid fine-needle biopsy: a systematic review

Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis

Efficacy of denosumab monotherapy among adults with Langerhans cell histiocytosis: A prospective clinical trial

Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis

Irisin: good or bad for the bone? A new path forward after the reported discovery of irisin receptor?

Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature

Adult Langerhans Cell Histiocytosis and the Skeleton

Gender Predilection in Sporadic Parathyroid Adenomas

Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation

The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?

Physiological parameters regulating circulating levels of the IGFBP-4/Stanniocalcin-2/PAPP-A axis

A Systematic Review of Cases Reporting Needle Tract Seeding Following Thyroid Fine Needle Biopsy

Novel therapies for osteoporosis

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab

Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease

Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature

Clinical Features of 24 Patients With Rebound‐Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases

Off-label uses of denosumab in metabolic bone diseases

Bone disease in primary hyperparathyroidism

Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients

Suchergebnisse filtern